Skip to main contentSkip to footer

STERIS announces EO expansions in malaysia and czech republic

March 17, 2020

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the expansion of ethylene oxide (EO) contract sterilization services within its existing facilities in Kuala Ketil, Malaysia and Velka Bites, Czech Republic.

The expansion of services in these regions furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future. The additional processing capacity complements existing gamma and EO operations in Kuala Ketil and EO operations in Velka Bites.

These expansions demonstrate our commitment to our Customers by ensuring that we provide increased capacity to meet the future demands for sustainable ethylene oxide processing and processing redundancy.

Malaysia-and-Czech

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.